| Logo | Name | Σ | Employees |
|---|---|---|---|
 | InFocus Therapeutics Innovating a New Class of Medicines to Drug the Undruggable InFocus is a discovery-stage biotechnology company dedicated to true innovation for novel therapeutic modalities. We are integrating unique experimental technologies with a state-of-the-art algorithm-driven drug discovery platform, to develop next-generation small molecule drugs against undruggable targets at unprecedented scale. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 11 |
 | Rosetta Omics Unlocking the road to precision medicine by tumor characterization via high resolution proteomic profiling. Worldwide, there are more than 20 million new cases of cancer each year. First-line therapies are not always the most effective and there is a strong need to move towards personalized medicine by offering the patients the best treatment as quickly as possible. This will help in increasing the chance or cure. Therefore, there is a need to improve the prediction of the response to treatments to be able to save patient’s lives and reduce the cost of expensive inefficient treatments. Our goal is to unlock … Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology A.I. - Machine Learning | 10 | 10 |
 | Abich_Lifeanalytics Cosmetics & MD Your partner in testing solutions Abich - Lifeanalytics is the Competence Center dedicated to Cosmetics and Medical Devices. Abich laboratories develops new and updated methods on biotechnology field to verify safety and efficacy of cosmetics and medical devices. The Clinical Trials Division also performs tests on healthy volunteers under the supervision of specialised personnel and in compliance with the standards for the sustainability of cosmetic claims and medical devices. Lifeanalytics, part of the CERBA Healthcare Group, was born from the union of 60 Italian companies that have over forty years of experience in analytical services of chemistry, microbiology and biology … Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 0 | 78 |
 | Cortex Technology ApS Few things are certain in life, but healthy skin will always be in style Cortex Technology – Empowering Skin Professionals for Exceptional Results Cortex Technology is a Danish manufacturer of advanced skin analysis tools and cryotherapy solutions for the medical and aesthetic industries. Since 1985, we have been at the forefront of clinical skin testing and cryosurgical innovation – trusted by dermatologists, aesthetic clinics, researchers, and professionals across the pharmaceutical, biotech, and cosmetics sectors. With nearly 40 years of experience, our mission is clear: to empower professionals by providing precise, user-friendly, and scientifically validated technologies that enhance treatment decisions, improve … | 0 | 20 |
 | MEDSENIC New therapeutic targets based on arsenic trioxide (As2O3) Founded in 2010, MEDSENIC is a biopharmaceutical start-up that aims to exploit the new possibilities offered by the therapeutic use of arsenic trioxide (As2O3) and thereby provide a treatment for patients with autoimmune diseases. santé, biotechnologies, bioparma, biopharmaceutical, biotech, health, biotechnology, autoimmune diseases, and maladies auto-immunes Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 4 |
 | AlpalifeBio AlpalifeBio, specialized in VHH Discovery solutions. Stay connected to explore the limitless potential of SdAb with us! Alpalifebio is a biotechnology company in China founded by scientists with strong background in antibody production, G protein coupled receptors (GPCRs) drug discovery. Now we exclusively engage in development and production of customized well-performed Alpaca Nanobodies (Single-domain antibodies or VHHs) in high-quality for cytoplasmic proteins, membrane proteins (especially GPCRs) and bio-medical research. AlpaLifeBio has been working with multiple top pharmaceutical companies in China, also built a good relationship with global clients, trying to provide every client the best service, quality and price. AlpaLife … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 8 |
 | Cell Environment Cyto-genomic technology to measure chromosomal health Cell Environment is a company created in 2016 that developed a new automated cyto-genomic approach combining new cytogenetics techniques with molecular genetics, based on 20 years of academic and private research. It allows to precisely analyse repetitive sequences (50% of the genome) as telomeres & centromeres and detect other chromosomal aberrations. This technology can be applied to better stratify populations for precision medicine in oncology for instance, to help diagnose some conditions as infertility or prenatal conditions, to measure toxic effects of certain treatments (in oncology) or of radiations, to measure the quality of … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 10 |
 | gradiant bioconvergence It is a company that is the first agency that has a global scale -derived organoid. Based on more than 400 organoid banking systems, garden -based platforms using autoimmune systems, genome analysis -based genetic variations, disease modeling using genetic scissors, and developing new drug -based growth factors based on ECM -based ECM -based growth factors, cooperation with leading domestic and overseas companies and institutions in the field of tumor and regenerative medicine. there is. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 10 |
 | BENTA Lyon French pharmaceutical laboratory and subcontractor, product and distributes generic drugs and DM Benta Lyon, French pharmaceutical laboratory and subcontractor, produces and distributes generic drugs covering various therapeutic fields, as well as medical devices. For more than 40 years, its 16 -hectare factory in the Aura region has been recognized as an operational center of excellence, specialized in the production of different pharmaceutical forms (dry, pastry, non -sterile liquids). Benta Lyon actively engages every day in relocation and health and industrial reconquest. By favoring manufacturing in France, the laboratory contributes to reducing dependence on imports and guaranteeing the availability of drugs … Type: SMB Activities: deeptech biotech manufacturing healthtech Technologies: Synthetic Biology | 19 | 59 |
 | CytobodX Tailor-made recombinant proteins CytobodX is a CRO company based in Marseille, France. At CytobodX, we produce, purify and characterize soluble and membrane proteins using state-of-the-art technologies to meet the specific needs of your research. The originality of CytobodX is to be able to rapidly produce native membrane proteins by using an innovative technology. Membrane proteins are directly expressed and embedded on the surface of purified Extracellular Vesicles (EVs) and ready for downstream applications : Interaction or functional studies, structural characterization or antibody/nanobody generation. This technology allows CytobodX to guarantee optimal quality and stability of the proteins produced and marketed. contact: … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 2 |
 | Takis Harnessing the immune system to fight cancer Takis is a biotech dedicated to cancer research. Our primary objective is the development of innovative therapies based on the principle that our immune system can be “instructed” to recognize the tumor and reject it as a foreign entity. For this purpose, Takis offers cutting-edge technologies and works with the idea that new cancer treatment must be based on in-depth knowledge of tumour biology and the concept of personalized cancer therapy. Together with some of its partners, Takis is involved in the identification of new biomarkers and in the development of molecular diagnostic … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 64 |
 | Pharmabiotic Research Institute (PRI) European Microbiome Regulatory Science Center The Pharmabiotic Research Institute (PRI) is Europe’s first Microbiome Regulatory Science expertise center – our purpose is to support and foster the development of innovative therapeutic and diagnostic products emerging from microbiome science, by bridging stakeholders in industry, academia, and EU regulatory representatives, for both human and veterinary medicine. Our mission is to educate and contribute to the conditions of success for future medicinal innovations emerging from microbiome science by supporting and communicating on regulatory science developments within and outside of our ecosystem. Our ultimate objective: see these therapeutic innovations achieve EU marketing authorization, thereby … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech | 1 | 13 |
 | Lutèce Dynamics See life in color. Microscope module and AI solutions for chemistry-free longitudinal imaging of 2D/3D live biosamples The aim of our company is to develop and commercialize a non invasive microscopy module for functional monitoring of 3D cultures of human cells and complex tissues. Based on almost 10 years of research in the lab, our technology measures a signal characteristic of cell metabolism, by measuring fluctuations in the amount of light scattered by cell organelles. Our optical design is integrated into a module that can be attached to any commercial microscope and is compatible with the state of the art. … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology A.I. | 6 | 2 |
 | Ksilink Patient-based drug discovery We design and apply unique patient-based cellular assays for large-scale phenotypic screening, leaning on the power of AI-driven image analysis. Integrated from bed to bench and back to bed, we aim to generate most efficient first-in-class therapeutic molecules for next generation medicine. AI image and data analysis, biology, high content screening, high throughput screening, deep learning, assay development, patient stratification, pyschiatric disorders, and cardiac muscle Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. Synthetic Biology | 4 | 23 |
 | Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) Improving the life of people with MS and neuroimmunological diseases through the development of innovative tools. The Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) is based on a non-profit foundation. It was founded in 2019 by the University Hospital Basel with participation of the University of Basel to continue and enhance the long-standing commitment and internationally renowned, clinically oriented research for patients with multiple sclerosis and other neuroimmunological diseases. RC2NB coordinates and supports several competitively funded research groups, dedicated to improving the clinical, imaging, biochemical, molecular, and cellular characterization of the disease process and understanding the benefits and … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech | 1 | 13 |
 | Firalis Molecular Precision CRO & CDMO | Streamlining your Drug Development Process, paving the way for a more Personalized Medicine. Firalis Molecular Precision (FMP) is a fast-growing CRO & CDMO, providing advanced and tailored BioAnalytical Testing services to the Life Sciences sector, based in Huningue, France and in Cambridge, USA. FMP's team leverages its extensive scientific expertise and cutting-edge in-house platforms to provide a range of services, namely sample storage and management, bioanalytical testing, omic data analysis and interpretation, assay development and production - delivering high-quality data to support you along the entire drug development process. FMP's mission is to provide healthcare professionals, … Type: Startup Activities: deeptech biotech Technologies: Data Analytics | 1 | 32 |
 | Recobia Therapeutics Breaking through barriers in subcutaneous administration of proteins Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 4 |
 | DFE Pharma Your medicines, our solutions. Moving to a healthier world. DFE Pharma is a global leader in pharmaceutical excipient solutions. We develop, produce and supply the highest quality functional excipients for use in the pharmaceutical, biopharmaceutical and nutraceutical industries for respiratory, oral solid dose (OSD), ophthalmic and parenteral formulations. Our excipients play an essential role as fillers, binders, disintegrants, and in stabilizing active ingredients for release in a predictable and effective manner into the patient’s system. With over a century of experience and over 400+ people worldwide in over 100 countries serving over 5,000 customers, DFE Pharma is committed to supporting … Type: Startup Activities: deeptech biotech healthtech | 1 | 528 |
 | Nikaia Pharmaceuticals Unlocking the power of NIK to transform the future of cancer and autoimmune disease treatment Nikaia Pharmaceuticals, an innovative company dedicated to the discovery and development of cutting-edge therapeutic solutions to improve patients' lives. 🔬💊 Our mission is to push the boundaries of science to deliver novel and effective treatments, focusing on the NIK protein (NF-κB-inducing kinase) and developing molecules capable of blocking its action. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 3 |
 | OXELTIS OXELTIS is an independent medchem oriented service company managed by former researchers from Idenix Pharmaceuticals and located in Montpellier - France. Oxeltis is a company that delivers integrated solutions for managing and executing medicinal and fine organic chemistry projects. We run FTE programs (hit to lead optimization) with an expertise in some specialty chemistry such as macrocycles (pseudopeptides), mono & poly/oligosaccharides (sugar phosphates, iminosugars, saccharidic antigens...) nucleos(t)ides (modified nucleosides, phosphoramidites...), short peptides, linkers and PROTACs (Ligands E3 CRBN ligase library ) applied to discovery programs in oncology, antivirals and antibiotics mainly. OXELTIS client portfolio includes 40+ European and US companies … | 1 | 23 |
 | TARIAN PHARMA Tarian Pharma's mission is to develop new drugs that ensure optimized cancer treatment by protecting cancer patients from side effects that would lead to dose reductions or discontinuation. This approach is designed to increase patients' chances of recovery and survival. Tarian Pharma was created by two dermatologists and a pharmacist, with more than 75 years of experience in the pharmaceutical industry and having been actively involved in the development and marketing of more than 15 new drugs in Europe, the United States and Asia. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 2 |
 | ACROBiosystems Where Proteins and Innovation Advance Biomedicine ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across the globe and maintains offices, R&D centers, and production bases in 12 different cities within the United States, Switzerland, England, Germany, and China. ACROBiosystems Group has established numerous long-term and stable partnerships with the world’s top pharmaceutical enterprises, including Pfizer, Novartis, and Johnson & Johnson, and numerous well-known academic institutes. The company comprises of several subsidiaries such as … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 4 | 146 |
 | Life Science Innovation Network Japan (LINK-J) Building Ecosystem to Create Innovation in Life Science LINK-J (Life Science Innovation Network Japan) builds platforms centered in Nihonbashi for networking and exchanging information with people around the world. We serve people involved in life science research and its industry in the broad sense including preventative, presymptomatic and health and longevity medicine such as regenerative medicine, precision medicine, drug development, medical devices and healthcare IT. By encouraging the activation and creation of an innovative life science industry in Japan and the world, we contribute to the larger vision of a society where we can live healthily and happily. Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech healthtech biotech | 1 | 12 |
 | VYNE Therapeutics Inc. For every therapeutic challenge, we question traditional assumptions and find better solutions. VYNE Therapeutics is a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immunological (I&I) conditions with high unmet need. Led by a proven and resourceful team of drug developers, VYNE is applying scientific innovation to advance novel therapies that have the potential to improve the lives of millions of people afflicted by autoimmune diseases. The catalyst of the company’s differentiated approach is its proprietary InhiBETTM Platform that potentially unlocks a promising new drug target for improving the treatment of challenging I&I diseases with … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 54 |
 | CRCT - Centre de Recherches en Cancérologie de Toulouse Basic research at the heart of oncopole The CRCT (Center for Research in Toulouse oncology) is a mixed research unit located on the oncopole website involving Inserm, the CNRS and the University of Toulouse. Currently, the CRCT hosts more than 400 research staff in 20 research teams, a technological center and a research support service. CRCT is structured in four scientific themes: oncogenic signaling and genetic instability, RNA and cancer, tumor microenvironment and metabolism, and onco-immunology. The CRCT benefits from close collaboration with the IRIT (Toulouse IT research institute), which welcomes a pilot team on an expert site in artificial … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech | 2 | 108 |
 |  Farmarin Indústria e Comércio Ltda Valuing lives! Since 1988 in the area of nephrology, Farmarin has been a pioneer in the production of polyelectrolytic concentrates for hemodialysis - CPHD in the national market. Initially consisting to supply some hemodialysis clinics in the city of São Paulo, it has had exponential growth over the years, meeting the growing demand for its products. In 2000, it changed its facilities to the city of Guarulhos, producing an industrial scale to serve the national and international market. Currently, he invests in new products to serve the hospital area in the country. In 2012, it was acquired by Medifarma S.A., … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 425 |
 | John Masters Organics Cultivating a future where clean beauty is the standard. Organic | Transparency | Integrity At John Masters Organics, we harness the power of nature to create safe, effective, and sustainable solutions that prioritize the well-being of our customers and the world we live in. In 1994, leading New York City stylist John Masters applied his own passion for healthy, holistic living into a pursuit of a gentler and more nourishing personal care routine. From humble beginnings in his Manhattan apartment, the John Masters brand grew from a few handmade products into a global line of hair care, skincare, body care, … Type: SMB Activities: biotech cosmetics Technologies: Bio sourced materials | 1 | 19 |
 | Labovet Produtos Veterinários For over 30 years we have been a reference in the production of veterinary vaccines and products. Proud to be 100% Brazilian. Labovet is a pharmaceutical industry that offers medicines and vaccines for small, medium and large animals. For over 30 years our focus is animal health, through high quality products and constant investments in research and modernization of our factory. We operate throughout Brazil with distribution centers at strategic points in the country, in order to have the best delivery condition and guarantee the good packaging of our products. Biological, therapeutic, hygiene, veterinary medicines, and vaccines Type: SMB Activities: pettech deeptech biotech Technologies: Synthetic Biology | 0 | 184 |
 | JDRF International As the leading global type 1 diabetes research and advocacy organization, Breakthrough T1D helps make everyday life with type 1 diabetes better while driving toward cures. We do this by investing in the most promising research, advocating for progress by working with government to address issues that impact the T1D community, and helping educate and empower individuals facing this condition. For more information, visit www.BreakthroughT1D.org Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 19 | 537 |
 | Micro-Fresh® The invisible technology that keeps products fresher for longer! Micro-Fresh® is an award-winning invisible technology that contains a natural active ingredient that blocks the growth of harmful and odour causing bacteria to keep products fresher for longer. It can be applied to almost any product during the manufacturing process. Micro-Fresh® supports footwear, textile, hospitality, health care, sportswear, and children’s sectors globally. Our Partners include; adidas, John Lewis, Next, M&S, Primark, Tesco, Asda, Sainsburys and Clarks Australia. Our technology preserves treated products and prolongs life leading to less landfill, eliminating the need for single use plastics stickers or silica gel packets … Type: SMB Activities: biotech fashtech deeptech Technologies: Bio sourced materials | 7 | 9 |
 | Biotech Dental Since its creation in 1987, Biotech Dental has been committed to building a trusting and lasting relationship with dental surgeons and dental technicians. Together, we design and develop a range of product that is continually more adapted to the challenges of the future. We have positioned ourselves at the crossroads of our customers’ expectations, innovation and technology. Giving dentists the ability to suggest the best products at the best price to their patients is Biotech Dental’s first objective. With more than 2 million dental implants sold, we have improved the lives of thousands of patients worldwide thanks to all the … Type: SMB Activities: biotech deeptech healthtech | 13 | 330 |
 |  Abtech Therapeutics Expertise in protein engineering | in silico & in vitro antibody discovery platform We work in partnership with technology platforms, pharmaceutical companies, and academic research groups to create next generation cell and molecular therapies. We integrate novel technologies into a synthetic antibody platform to provide the most advanced discovery engine possible. Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 2 |
 | ThePowerHouse ThePowerHouse was a leading innovation agency for FashionTech and wearable technology until 2022. ThePowerHouse was a leading innovation agency for FashionTech and wearable technology. The interdisciplinary team of creative technologists, makers, and fashion designers contributed to a European cluster effort for Creative Industries. The company seized its activity in 2022 when its founder Lisa Lang moved on to work in the European policy space in Brussels. Our work encompasses rapid prototyping, consulting, matchmaking and education. We love taking on challenges and ideas that have never been created before. We love pushing the boundaries of the status quo and designing for … Type: Startup Activities: fashtech biotech deeptech transporttech Technologies: IoT | 1 | 1 |
 | OncoDNA OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. The company helps clinicians, academic researchers and biopharma companies to outsmart molecular complexity with the mission of delivering the promise of precision medicine. The company not only provides clinical guidance for the treatment and real-time monitoring of late-stage cancer patients but also supports research and drug development in cancer and genetic diseases. Since its early days in 2012, OncoDNA has grown into a corporate group of companies with world-renowned expertise. The Group offers a unique portfolio that combines NGS services, biomarker … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 12 | 48 |
 | Cellaïon Cell Signaling Technology for Organ Repair and Regeneration Cell Signaling Technology for Organ Repair and Regeneration We care for liver Our advanced therapy aims to restore liver function thanks to immunomodulatory and regenerative properties of Hepastem Cell therapy, Acquired liver diseases, Liver diseases, liver based genetic diseases, NASH, ACLF, Antibodies, Clinical stage, Chronic liver disease, Fatty liver, Acute liver disease, Regenerative medicine, Biotech, and Biotechnology Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 20 |
 | Kura Oncology, Inc. Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives. Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura’s pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806. Ziftomenib is a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction for the treatment … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 244 |
 | Gritstone bio A clinical-stage biotech company that aims to develop the world’s most potent vaccines for cancer and infectious disease Gritstone bio brings together a group of distinguished scientific founders and advisors, a highly experienced and diverse leadership team and a seasoned and successful board of directors to develop the next-generation of vaccines for cancer and infectious disease. With our unique approach to immuno-oncology and infectious diseases, we seek to generate a therapeutic immune response by leveraging insights into the immune system’s ability to recognize and destroy diseased cells by targeting select antigens. We started with a focus on tumor-specific neoantigens and … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 58 |
 | Cellarity Rewriting the rules of drug creation Cellarity is fundamentally redesigning the way drugs are created. By shifting the focus from a single target to the underlying cellular dysfunction, the company unravels the complexity of disease biology to create medicines that are out of reach with the target-based drug discovery approach. Founded by Flagship Pioneering in 2017, Cellarity has developed a platform that utilizes proprietary AI models trained on over 30 million single cell transcriptomes to uncover novel actionable biology and create non-intuitive drug candidates in a vast array of diseases. The company currently has programs ongoing in several disease areas … Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology | 4 | 104 |
 | Ansa Biotechnologies, Inc. High-fidelity DNA synthesis using enzymes At Ansa Biotechnologies, we’re developing a way to synthesize DNA that will accelerate innovation in medicine, agriculture, and industrial biotechnology. Our fast, clean, and accurate enzymatic DNA synthesis process can produce gene-length molecules directly, overcoming bottlenecks of traditional DNA synthesis methods. We envision a future where our technology empowers scientists to develop solutions for the world's biggest problems in health and sustainability. Note that Ansa does not conduct any employment discussions via LinkedIn. All official Ansa career openings are exclusively listed on our website careers page. DNA | 0 | 79 |
 | Camena Bioscience Unlocking access to genes with unparalleled accuracy Our mission is to enable synthetic biologists, by using our technology to unlock access to genes with unparalleled accuracy. We produce genes for a range of biotechnology customers including those in the pharmaceutical, agriculture and diagnostics sectors. Our technology offers access to long and complex gene sequences, which are normally difficult to produce. We are based in Cambridge UK, but we serve companies across the world. Camena's technology is positioned to enable researchers and the synthetic biology revolution. Twitter: @camenabio DNA synthesis, Complex genes, Synthetic Biology, synbio, and Gene synthesis Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 31 |
 | Ribbon Bio Making The Impossible Possible We are redefining scientific possibility with our algorithm-driven technology that produces pristine synthetic DNA molecules, enabling our partners to deliver a new generation of transformative solutions for the health of people and planet. Type: Startup Activities: deeptech biotech Technologies: SaaS | 1 | 55 |
 | Nuclera Bring rapid protein access to your benchtop with eProtein Discovery At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow researchers to accelerate their protein projects. Fail fast, succeed faster. Our eProtein DiscoveryTM system automates construct screening for the best soluble expression and purification yields of different proteins in under 24 hours. From there, protein scale-up happens the next day (up to the mg scale) right on the benchtop - delivering reliable protein in-hand in less than 48 hours. Nuclera’s technology … Type: Startup Activities: biotech Technologies: Synthetic Biology | 7 | 124 |
 | Syncath Neuroscience Multimodal diagnostic and therapeutic platform for the Neuro ICU Syncath Neurosience is focused on diagnostics and therapeutics for brain edema and elevated intracranial pressure such as in traumatic brain injuries, subarachnoid hemorrhage and intracranial hemorrhage Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology SaaS | 0 | 2 |
 | Synchron Brain Computer Interface Synchron is developing implantable neurotechnology to unlock the brain and solve unmet medical needs at scale brain computer interface, neuroprosthesis, neuromodulation, neuromonitoring, neurotechnology, medtech, biotech, machine learning, and signal processing Type: Startup Activities: deeptech biotech Technologies: Data Analytics | 11 | 134 |
 |  Cartesian Therapeutics Pioneering RNA cell therapy for autoimmune disease Cartesian Therapeutics is a clinical-stage company pioneering mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a potential first-in-class mRNA CAR-T in Phase 2b clinical development for patients with generalized myasthenia gravis and Phase 2 development for systematic lupus erythematosus, with a Phase 2 basket trial planned in additional autoimmune indications. The Company’s clinical-stage pipeline also includes Descartes-15, a next-generation, autologous anti-BCMA mRNA CAR-T. For more information, please visit www.cartesiantherapeutics.com Immunotherapy, Oncology, Molecular Biology, Immunology, Myasthenia Gravis, ARDS, Cell Therapy, NETs, Gene Therapy, Cancer Research, multiple myeloma, … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 75 |
 | SIRNAOMICS Sirnaomics is an RNA therapeutics biopharmaceutical company that focuses on the discovery and development of innovative drugs for indications with unmet medical needs and large market opportunities. Sirnaomics is the first clinical-stage RNA therapeutics company to have a strong presence in both Asia and the United States. Based on its proprietary delivery technologies, a polypeptide nanoparticle RNAi platform and GalNAc RNAi platform, GalAheadTM, Sirnaomics has established an enriched drug candidate pipeline. STP122G, which represents the first drug candidate utilizing the Group's GalAheadTM mxRNA technology, is currently in Phase I development. STP125G is the second siRNA therapeutics based on Sirnaomics proprietary … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 36 |
 | Biomica Ltd. Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics. Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing Evogene's Computational Predictive Biology (CPB) platform. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 20 |
 | Oisin Biotechnologies Genetic medicines for age-related diseases Oisin Biotechnologies is a longevity therapeutics platform company focused on creating genetic medicines to combat a variety of age related diseases. When cells detect that they have been irreversibly damaged, they enter a non-dividing condition known as cell-cycle arrest, or senescence. It’s believed this occurs to prevent cells from going rogue and turning cancerous. Ideally, they should die by the process known as apoptosis, but as we age, more and more frequently they don’t. They become zombie cells – unable to kill themselves or resume normal function. Senescent cells secrete molecules that cause inflammation in … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 17 |
 | BioAge Labs We are harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. BioAge is a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. Our proprietary platform, which encompasses >65M molecular measurements spanning 45+ years of human aging, unlocks a universe of novel biological insights and druggable mechanisms for age-related disease. The company’s lead program, azelaprag, is a potential first-in-class oral APJ agonist entering Phase 2 trials in combination with tirzepatide for the treatment of obesity in older adults. Azelaprag has the potential as … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 90 |
 | cellvie Levearging the therapeutic potential of mitochondria cellvie is the leader in Therapeutic Mitochondria Transplantation (TMT). The team is seeking to bring about a novel treatment modality, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell. Therapeutic Mitochondria Transplantation, an approach for mitochondria augmentation and replacement, was developed by Dr. James McCully at Harvard Medical School. cellvie was founded to take this technology from bench to bed, starting in heart attacks and solid organ transplantation. Therapeutic Mitochondria Transfer, Mitochondria, Ischemia-Reperfusion Injury, and Solid Organ Transplantation Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 14 |
 | Boltzmann We build machine learning applications for the core processes of your company. With our team of PhD-level data scientists we love to tackle challenging use cases centered on Machine Learning. Our main experience lies with ML R&D for innovative SMEs and accelerating ML tracks in corporates. Both challenging in their own way. Each time we focus on the ML part of the use case which typically result in plug-ins for existing workflows. We pride ourselves in communicating clearly about data and we love to train your budding data team and prepare them for handover. And with our own product Ludwig … Type: Startup Activities: it services biotech deeptech fintech Technologies: A.I. A.I. - Machine Learning Data Analytics | 0 | 7 |
 | ProDigest SHIME technology & preclinical gastrointestinal expertise We are a dynamic pre-clinical CRO offering the best-in-class in vitro simulations of the gastrointestinal tract to (functional) food, feed and pharma industry. A strong team, the desire to innovate and our customers’ satisfaction are at the core of our DNA. Our long-standing expertise and tailormade solutions support your research from early phases to the final stages of product development. ProDigest is the company that brings on the market the SHIME® platform (Simulator of the Human Intestinal Microbial Ecosystem) and related technologies (Colon-on-a-plate®; Diamod®; MetaKey®) Gastrointestinal microbial ecology, Clinical trials, Molecular analyses, In vitro … Type: Startup Activities: biotech deeptech Technologies: SaaS | 5 | 50 |
 | Confo Therapeutics Exploiting the conformational complexity of GPCRs to innovate drug discovery Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets. This technology platform combined with the pharmacologic and biologic insight it provides, allows Confo to build a multi-indication pipeline of drug candidates with the potential to transform therapeutic outcomes for patients with severe illnesses lacking disease-modifying treatments. Confo Therapeutics was spun out of Vrije Universiteit Brussel (VUB) and VIB in 2015. Supported by international life-science focused investors and led by an experienced team of entrepreneurial professionals … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 72 |
 | OUAT! Humanizing the life science industry 4.0 with visual digital twins. OPERATIONAL EXCELLENCE. MADE SIMPLE. Our mission is to facilitate the digital transformation of the life sciences industry. At the time of a new industrial revolution, we are convinced that if factories must become smart and connected, the men and women remain the beating heart of production activities. To achieve this transformation for all and by all, it is necessary to rethink human-machine-data interactions. By leveraging intuitive 3D digital twin technologies, we empower the biopharmaceutical workforce to easily access data and optimize bioproduction processes from planning and simulation, to operators' learning … | 8 | 75 |
 | FINDMED Ensemble, faisons passer vos projets d'innovation à l'étape suivante ! Founded in 2015, the FINDMED consortium brings together 16 Carnot institutes with one common and ambitious goal: strengthening the competitiveness of the French health industry. The Carnot institutes are French academic research institutions dedicated to setting up collaborative research partnerships. The consortium gathers 7 of them dedicated to drug and health research: Pasteur Microbes et Santé, Curie-Cancer, Voir et Entendre, the Brain and Spine Institute, France Futur Elevage, CALYM and Imagine - and 9 more which provides additional expertises: Chimie Balard Cirimat (chemistry, formulation), Innovation Chimie Carnot (medicinal chemistry, bioproduction), … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech healthtech biotech | 0 | 1 |
 | Redox Medicine Society Imagine, Invent, Inspire On the occasion of the 25th anniversary of the International Society of Antioxidants in Nutrition and Health, ISANH, the founder and the scientific committee decided to change ISANH into the Redox Medicine Society. Dr. Carole Nicco was announced the new President of the Redox Medicine Society. ISANH was established 25 years ago to discuss research on free radicals and their implications in various human pathologies. During the Paris Redox 2022 Conference, the Scientific Committee discussed how to transform ISANH, how to face new challenges and how to redesign the strategies as it is now time to update … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech healthtech biotech | 1 | 1 |
 | SenzaGen Non-animal toxicity testing – experts in "difficult-to-test" samples SenzaGen aims to be a leader in in vitro science and testing, driving the transition from animal testing to methods better suited to reflect human biology. The Company provides high-performance, non-animal test methods and innovation and consulting services based on state-of-the-art technology. Non-animal methods are more effective, more accurate and less expensive than traditional animal-based methods while also helping to reduce the number of laboratory animals. The Company has a growth strategy centered around continued commercialization of its proprietary GARD® test platform, expansion of its test portfolio and evaluation of acquisition opportunities … | 0 | 25 |
 | Embleema Embleema is the regulatory-grade health data platform to accelerate new drug discovery and release new treatments sooner Embleema's software platform brings precision medicine sooner to patients by collecting and generating regulatory-grade evidence. Our platform natively unifies clinical, molecular and real-world data and is the sole one used by the FDA for its regulatory evaluation of health products involving genomic datasets. The protocols and algorithms contained in our platform are also the basis for future CDISC standards for cell and gene therapies. The FDA also uses our platform to produce regulatory grade genomic sequences for SARS-CoV-2 and other microbial pathogens (project … Type: Startup Activities: healthtech biotech deeptech Technologies: Blockchain/Cryptocurrency | 10 | 24 |
 | Spiral Therapeutics delivering therapies for inner ear disorders We are a clinical stage company delivering therapies for inner ear disorders hearing loss, pharmaceuticals, Meniere's Disease, and drug delivery Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 9 |
 | Mycorena Let's co-create with mycoprotein! Mycorena is now part of Naplasol, where we bring you Promyc®—100% natural mycoproteins that offer a sustainable solution for consumer food, feed, and pet food products. Our semi-finished, protein-rich base features a unique, versatile structure, a neutral taste profile, and unparalleled nutritional value. Harnessing the power of nature through our innovative fungi fermentation process, we produce Promyc at scale, with the capacity to deliver thousands of tons annually. Based in Bree, Belgium, Naplasol is your dedicated mycoprotein specialist and a proud member of the VEOS Group, a global leader in the protein market. Promyc can be … Type: Startup Activities: biotech civictech cleantech deeptech greentech Technologies: Bio sourced materials | 17 | 4 |
 | Organovo Holdings, Inc. Discovering drugs using highly customized human tissues as living, dynamic models of human biology and disease. We are pioneering a unique set of therapeutic and drug profiling capabilities based on our revolutionary ability to 3D bioprint tissues that mimic key aspects of human biology and disease. We intend to fundamentally alter the drug discovery landscape by the development of novel therapies for disease which have a much higher chance of efficacy in the clinic focused on human primary cell 3D models of disease that more faithfully recapitulate disease processes. Learn more at www.organovo.com. 3D bioprinting, 3D printing, Drug discovery and … Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology | 0 | 31 |
 | Amwell Conversa Health Conversa Health was fully integrated into Amwell in 2022. At Amwell, we digitally empower our clients’ health care ambitions. It starts with our future-ready platform—a convergence of technologies, services, and devices that enables care delivery at scale, anytime and anyplace. But it’s not just products, it’s partnership. We connect providers, payers, and innovators, working alongside them to create an ecosystem of care that spans across in-person, virtual, and automated care. Powered by dedicated experts and industry-leading technology, we fulfill our commitment to reliable execution today and in the future. And behind everything we do is an unwavering pursuit of better … Type: Startup Activities: healthtech deeptech biotech Technologies: SaaS | 6 | 7 |
 | Celmatix Therapeutics The future of women's health therapeutics is here. Celmatix Therapeutics is a preclinical-stage women’s health biotech focused on advancing groundbreaking therapeutics for women’s health. With its growing pipeline of innovative drug programs including an AMHR2 agonist program focused on ovarian aging, an oral FSH for infertility, and a JNK inhibitor program for endometriosis, Celmatix Therapeutics is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in women’s health. For more information, visit the company’s website at www.celmatix.com. Reproductive Biology and Medicine, Genomics, Bioinformatics, Biotech, Women's health, and Drug Development Type: Startup Activities: biotech healthtech deeptech Technologies: Synthetic Biology | 10 | 24 |
 | Inizio Evoke We are purpose-built to make health more humanTM. Inizio Evoke is a global health marketing, communications, and transformation platform unlocking growth through data-driven insights and human centricity. We are purpose-built to make Health more humanTM. With core expertise and specialty brands in Marketing, Comms, Transformation, Access, and Media, we serve as a premier partner for the world's most ambitious healthcare organizations. Inizio Evoke is an Inizio company. Inizio helps clients navigate their clinical development and commercialization journey by connecting best-in-class scientific knowledge, market intelligence, actionable data, cutting-edge technology, communication, and creative execution. Healthcare Marketing, Digital Strategy, Multichannel Marketing, Web Development, … Type: Startup Activities: martech consulting deeptech healthtech biotech Technologies: Data Analytics | 25 | 1,150 |
 | MetaGenoPolis INRAE unit of metagenomics expertise. Nutrition & health #microbiome research, human & animal. ISO 9001 certified. CIR MetaGenoPolis (MGP) is an INRAE unit expert in gut microbiome research applied to human and animal health and nutrition, funded by the Programme des Investissements d'Avenir (Laureate 2012 and 2019). MGP's expertise in the analysis of the gut microbiome and its implications for health and nutrition has been widely recognized in the international scientific community since 2010. In collaboration with industry, academia and clinics, MGP conceives and implements projects tailored to the partner’s need. ISO 9001 certified, the protocols and procedures are constantly … Type: Public Activities: biotech deeptech healthtech | 28 | 28 |
 | Histalim A division of Cerba Research For nearly 10 years HISTALIM provides services in the fields of histology, cytology and molecular biology for clients from a wide range of sectors including human and animal health, dermo-cosmetics, chemistry, environment, agronomics, agri-food industry... Ranging from neurosciences to toxicity assessment, from the characterization of therapeutic antibodies to the evaluation of implantable medical devices..., our teams focus on accompanying each client to provide each of them with a perfectly controlled service. Our histological technical resources, our European network of histopathology experts, and our techniques in image processing and analysis enable us to meet efficiently each … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 12 |
 | GLYcoDiag Glycoscience and microbiota research specialized company GLYcoDiag is a French research company (SME) specialized in glycosciences and microbiote services and product. Our business area covers the domains of human and animal health (biomarkers, therapeutic recombinant glycoproteins, vaccines), cosmetics (active ingredients, design and mechanisms of “glyco-actives”) and environment (biofilms, waste water). glycobiology, lectins glycoprofiling, oligosaccharides, glycoconjugates, microbiota, glycosciences, and cosmetics Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 3 |
 | EDELRIS We focus our effort to create value for your projects. EDELRIS is a pioneering company dedicated to the design and chemical synthesis of innovative natural product-like screening Libraries, medicinal chemistry Hit-to-Lead / Lead Optimization projects, Custom Synthesis, and Affinity screening-Mass Spectrometry (AS-MS). Aiming at the acceleration of the lead discovery and optimization process in pharma and biotech research organizations, EDELRIS uses its recognized chemistry and screening expertise in drug discovery to provide novelty to its clients and partners. Our unique and first-in-class NP-like, easily tractable screening libraries (Fragments, Covalent binders, conventional HTS & DEL) now contain +2M in-house synthesized compounds, … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 59 |
 | GENOOX Genoox harnesses the power of its community to enable actionable insights, serving professionals at the point of care Genoox harnesses the power of its community to enable actionable insights from the largest real time-real life genomic database serving professionals at the point of care. Genoox’s cloud-based AI platform, Franklin, connects clinicians, genetic counselors and healthcare organizations, while enabling platform users to make impactful discoveries using the most advanced genomic tools and applications. Genoox is used by over 1,700 health organizations, hospitals and medical facilities in 44 markets across the globe. Bioinformatics, Genomic analysis, Genome interpretation, Precision Medicine, Clinical Trial Matching, … Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. | 1 | 57 |
 | LXMI Social impact-sourced, plant-based, and mindfully crafted holistic wellness, creating vitality for you and the planet. LXMI, pronounced /luxe-me/, is committed to three distinct brand tenets: • Rare ingredients from unique terroir • Going beyond charity to #givework to women • Potent organic botanicals with rare #PlantPower Named after the Hindu goddess of beauty, Lakshmi, whose four hands represent prosperity, liberation, morality and love – our seal shows two hands giving, and two hands receiving. Leila Janah founded LXMI after a chance discovery of Nilotica, LXMI’s signature ingredient, at a market in Uganda. She was astounded by the rare butter’s ability … Type: Startup Activities: biotech deeptech cosmetics Technologies: Bio sourced materials | 0 | 29 |
 | Kean Health Stop guessing. Start testing. Powered by Psomagen Stop guessing. Start testing. We offer a no band-aid approach to personalized wellness management. Backed by science and trusted by experts, we like to think of ourselves as the G.O.A.T. for at-home testing. For the past 17 years we have worked with the biggest and most trusted brands in the healthcare industry. Now we are bringing our expertise straight to you, in the comfort of your own home. We are fun, highly specialised, bold, unique and passionate about giving you control and clarity for your lifetime journey of continued wellness. With our clever … Type: Startup Activities: biotech deeptech healthtech | 7 | 15 |
 | Lucence Bringing Clarity to Cancer Care Lucence is a precision oncology company committed to bringing clarity to cancer care. Lucence makes ultrasensitive non-invasive liquid biopsy tests to provide doctors and their patients life-changing information to enable earlier detection and effective treatment. Headquartered in Palo Alto and Singapore, Lucence supplies personalized cancer care services through twin CLIA-licensed laboratories in the United States and Singapore. For more information, visit www.lucence.com. liquid biopsy, NGS, diagnostics, genomic medicine, cancer genomics, and oncology | 2 | 82 |
 | Aigenpulse The Data Intelligence Platform for Life Sciences A scientific data management and machine learning platform for Life Sciences. Aigenpulse is a data management and machine learning platform for scientific data generated within the field of Life Sciences. We address the ever increasing volume of data challenges by consistently integrating scientific data and analytics routines employed within an organisation and provide a bespoke, secure enterprise data management and analytics platform. Working with our clients, we digitalise analytical processes enabling scientists to refocus their attention onto what they value the most - research and interpretation of research results. In the world of … Type: Startup Activities: deeptech biotech it services Technologies: Data Analytics A.I. A.I. - Machine Learning A.I. - Deep Learning | 14 | 1 |
 | Nebula Genomics Understand your genome. Help cure diseases. Own your data. Powered by blockchain. Type: Startup Activities: biotech deeptech Technologies: Blockchain/Cryptocurrency | 6 | 11 |
 | Curology Inspiring confidence that goes deeper than skin - we're hiring! At Curology, we understand that accessibility to clear skin can transform lives. That’s why we provide personalized prescription medications, custom-formulated to address each patient's unique skin concerns, conveniently delivered right to their doorstep. Our expertise in acne and anti-aging solutions enables us to offer highly effective and affordable care tailored to our patients' specific needs. We are driven by a mission to inspire confidence that goes deeper than skin. Our dedicated team of dermatology providers is committed to making professional acne care accessible to millions of individuals. We facilitate 1:1 … Type: Startup Activities: biotech deeptech healthtech Technologies: SaaS | 5 | 225 |
 | Backyard Brains Backyard Brains enables everyone to be a neuroscientist! We provide affordable neuroscience experiment kits for students of all ages to learn (hands-on) about electrophysiology. Now everyone from schoolchildren to grad students and every grade in between can experiment with similar tools used by real neuroscientists worldwide! By following a few simple steps, everyone can experience first-hand how the brain communicates with our sense, memories, hopes, and desires. Neuroscience, Engineering, Teaching, and Experiments | 7 | 22 |
 | Protequus® Equine Health & Safety Protequus® is a biomedical engineering and data science firm in Austin, Texas dedicated to equine health & safety and the developers of NIGHTWATCH®. Founded in 2013 after the sudden loss of one of his horses to colic, Jeffrey R. Schab—an accomplished equestrian and biomedical engineer—assembled a team of passionate science & technology professionals to find a solution to combat the devastating impact of colic, which claims the lives of ~50,000 horses each year in the US and results in more than $700 million in annual losses. The NIGHTWATCH® smart halterTM is an equine distress & wellness … Type: Startup Activities: biotech deeptech Technologies: IoT A.I. A.I. - Machine Learning Wireless Data Analytics | 0 | 3 |
 | ASCENSCIA - AI Voice Assistant for Research Labs An AI voice assistant designed for research labs. ASCENSCIA is an AI voice assistant that enhances data management in R&D labs. ASCENSCIA integrates seamlessly with various lab systems (ELNs & LIMS) and lab machines to enable scientists to document and access data through simple, hands-free voice commands. Our mission is to accelerate drug discovery innovation and reduce R&D costs through better and more efficient data management. Drug Discovery, Biomedical Research, Pharmaceuticals, Digital Transformation, Lab Connectivity, and Lab Solution Type: Startup Activities: biotech deeptech Technologies: A.I. Generative A.I. Data Analytics | 3 | 4 |
 | NVision Imaging Technologies Leveraging quantum technology to enable imaging of cell metabolism via hyperpolarized MRI At NVision, we engineer quantum-powered medical imaging technologies that deliver deeper, more precise MRI data for researchers and clinicians. Our unique hyperpolarization device POLARIS enables fast, simple, scalable imaging of metabolism at the cellular level. With hyperpolarized MRI, we are paving the way for earlier detection, faster treatment assessment and better risk profiling in oncology, cardiology, neurology and beyond. MRI, NMR, and Quantum Optics Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 79 |
 | Blackrock Neurotech Implantable brain technology changing lives. Blackrock Neurotech is a team of the world’s leading engineers, neuroscientists, and visionaries. Our mission is simple: We want people with neurological disorders to walk, talk, see, hear, and feel again. We’re engineering the next generation of neural implants, including implantable brain-computer interface technology that restores function and independence to individuals with neurological disorders. Join us in changing lives today. Connect with us: Join Our Team | https://bit.ly/3bCsXRv LinkedIn | https://bit.ly/3PfifOL Twitter | https://bit.ly/3PfifOL Instagram | https://bit.ly/3bMaYrW Facebook | https://bit.ly/3JRc2av Clinical Trials | https://bit.ly/3A8QPWm Our site | https://blackrockneurotech.com Additional information: As the world leader in … Type: Startup Activities: healthtech biotech deeptech Technologies: Affective Computing | 9 | 164 |
 | SUITX (!) Page closing soon => follow us on our new "SUITX by Ottobock" channel We are merging LinkedIn Channels. Please DO NOT follow this page, instead, we welcome you on SUITX by Ottobock https://www.linkedin.com/company/exoskeletons/ SUITX designs and produces exoskeletons. It's our mission to offer wearable technology that protects workers’ health and creates healthier working conditions. Ottobock and SUITX have joined to become a world leading provider of occupational exoskeletons. Ottobock and SUITX are combining their expertise and products to take the exoskeleton market to a new level and to foster the worldwide adoption of exoskeletons. For over ten years, we have been developing wearable technologies that make people’s lives easier. The focus of our … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 24 |
 | Helix Helix is the leading population genomics and precision health organization. We enable health systems, life sciences companies and payers to accelerate the integration of genomic data into patient care and therapeutic development. Learn more at www.helix.com Next Generation Sequencing (NGS), Bioinformatics, Big Data, DNA, Population Health, Population Genomics, Precision Health, Precision Medcine, Exome Sequencing, Medical Research, and Health System Strategy Type: Startup Activities: healthtech biotech deeptech martech Technologies: Data Analytics | 9 | 536 |
 | CartilaGen Inc. Changing the paradigm of osteoarthritis treatment! CartilaGen Inc. is developing an intra-articular injection of a small-molecule drug capable of preventing post-traumatic osteoarthritis. CartilaGen's solution aims to provide an unprecedented disease-modifying treatment to an area of medicine that remains an unmet medical need. Osteoarthritis, Biomaterials, and Preventative Medicine Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 3 |
 | mediri GmbH Your One-stop shop for imaging studies What drives us is the ambition to offer state of the art medical imaging solutions which help to make the society advance. Clinical trials are the essence of evidence-based medicine, and therefore one core element to tackle emergent societal challenges like dementia, stroke and cancer. Artificial intelligence (AI) is the future in patient-individual diagnosis support. By establishing cost-effective AI solutions, patients will benefit most from the ongoing advances in machine learning based research. Since the foundation of mediri in 2004, we accompany our customers to improve services and data quality in clinical trials and … Type: SMB Activities: healthtech deeptech biotech Technologies: A.I. A.I. - Image Processing | 1 | 10 |
 | AOBiome Therapeutics, Inc. AOBiome is focused on transforming human health by developing microbiome-based therapies for inflammatory conditions. AOBiome Therapeutics, Inc. is a Cambridge, MA-based life sciences company focused on transforming human health by developing microbiome-based therapies for local, nasal and systemic inflammatory conditions. Founded in 2012 by PatientsLikeMe founder Jamie Heywood and MIT-trained Chemical Engineer David Whitlock, AOBiome is advancing a pipeline of multiple, clinical-stage therapeutic candidates. The company's portfolio includes multiple clinical-stage programs: a completed Phase 2 study to treat patients with acne vulgaris or acne, a Phase 1b study to treat patients with pediatric eczema (atopic dermatitis), a Phase 2a study … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 16 |
 | Color The only solution fully-focused on cancer - for your full workforce. Color Health is changing the way patients access cancer care through a first-of-its-kind, vertically integrated, and fully owned Virtual Cancer Clinic. Powered by a 50-state licensed team of cancer-focused clinical experts, Color provides proactive, evidence-based care that is accessible to anyone, anytime, and at every step of the cancer journey. We partner with employers, health plans, unions, and government agencies to improve accessibility of early interventions, timely diagnosis, oncology care management, and survivorship care. By enabling timely, risk-based interventions at every step of the cancer journey, Color drives earlier … Type: Startup Activities: biotech it services healthtech deeptech Technologies: Data Analytics | 20 | 599 |
 | TissueGen, Inc. TissueGen is a developer of next generation drug delivery technologies. TissueGen solves for unmet needs through the development of transformative drug delivery technologies that reduce treatment burden and improve clinical outcomes. We create life changing treatment modalities for patients and their caregivers, treating both acute and chronic conditions. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 11 |
 | Perfect Corp. Leader in AI & AR-powered Beauty & Fashion Tech, Expert in Transforming Consumer Experiences Perfect Corp. (NYSE: PERF) leverages ‘Beautiful AI’ innovations to make our world more beautiful. As a pioneer and leader in the space, Perfect Corp. works with over 600 partners around the globe to empower brands to embrace the digital-first world by transforming shopping journeys through digital tech innovations. Perfect Corp.’s suite of enterprise solutions deliver synergistic, technology-driven experiences that facilitate sustainable, ultra-personalized, and engaging shopping journeys through hyper-realistic virtual try-ons, AI-powered skin analyses, personalized product recommendation tools and many more Beautiful AI innovations. Perfect Corp. has … Type: Startup Activities: biotech deeptech fashtech it services Technologies: SaaS A.I. VR | 8 | 322 |
 | iXensor The Pioneer of Mobile Health iXensor is the pioneer of mobile health. We turn ordinary smartphones into versatile lab-grade medical diagnostic devices for point-of-care testing and at-home self-testing solutions. PixoTest®, our first product, is also the world's first FDA-approved smartphone camera-based blood test dated back in 2017. The founding team of iXensor first met at Stanford University in 2011. At that time, they saw the rise of the smartphone and its potential to reshape future healthcare. In 2012, iXensor was founded in Silicon Valley and then incorporated in Taipei, Taiwan. Our interdisciplinary team combines expertise in medical engineering, biochemistry, and … Type: Startup Activities: healthtech biotech deeptech Technologies: Data Analytics | 5 | 27 |
 | INCREDIBLE® (formerly JuiceInnov8) Building the next generation of food & beverage that are healthier for everyone and greater for this planet—with biology INCREDIBLE® BIO (formerly JuiceInnov8) was founded under the mission to build the next generation of food & beverage that is healthier for everyone and greater for this planet (and perhaps, Mars) with the power of biology. We are a food-biotechnology startup, born and bred by engineers, scientists, marketers, challengers, and rebels who're crazy enough to believe that we can make things we eat & drink beyond just better. We harness the power of nature with a twist of science to create … Type: Startup Activities: biotech deeptech agritech Technologies: Synthetic Biology | 0 | 20 |
 | BioSistemika High-quality digital solutions for laboratories BioSistemika specializes in custom software development, digitalization consulting, and development of laboratory software products. Over the past 10 years, we have worked with many laboratory instrument manufacturers and delivered software products that were tailored to our customer needs. We have completed several in vitro diagnostic (IVD) projects and non-IVD software projects for our customers for which we developed entire software product suites, starting from requirements, design specification, coding, and testing. For IVD, we are working in accordance with ISO 13485 and IEC 62304. We have vast experience in software-hardware integrations and are supporting standardization efforts … Type: Startup Activities: deeptech biotech Technologies: SaaS | 2 | 44 |
 | X-ZELL Enabling same-day cancer diagnostics from minimally invasive sample material X-ZELL is an award-winning medical technology start-up specialising in next-generation cytology. Cytology – or cytopathology – is the science of diagnosing diseases by examining single atypical cells or cell clusters. X-ZELL has developed a plug-and-play solution for the detection, visualization and digitization of these phenomena in minimally invasive body liquids. Slotting seamlessly into clinical routine, it does not require complex specimen preparation and reduces the average time from sample to diagnosis from 48h to less than 4h. The result: better diagnostics and improved patient care. X-ZELL is headquartered in Singapore and … Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. Synthetic Biology | 8 | 20 |
 | F-star Therapeutics Innovation focused private biotech dedicated to delivering next-generation multispecific antibody therapeutics. F-star is a private biotech, based in Cambridge UK, focused on using our world-leading, innovative bispecific antibody technology that is clinically validated, patent protected and designed to create therapeutics that help more people with cancer and other serious diseases live longer with improved lives. bispecific antibodies, immuno-oncology, Immmunotherapy, oncology, cancer, tetravalent bispecifics, cancer research, biotech, immunology, CNS, and autoimmunity Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 39 |
 | Takeda in Belgium Better Health, Brighter Future Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history, originating in Japan. As a global leader with presence in over 80 countries and regions, our therapeutics focus on Gastro-enterology, Oncology, Rare Diseases, Neuroscience, Plasma-Derived Therapies and Vaccines. In Belgium, Takeda is one of the 10 largest pharmaceutical companies, with its local head office located in Zaventem, close to Brussels Airport. Day after day, our … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 5 | 260 |
 | ONCOLille Gathering interdisciplinarity to fight cancer! The Lille Interdisciplinary Research Institute in Cancerology, called Oncolille, was created on January 1, 2020. The institute will be located on the university hospital campus at the interface of the 2 care establishments: the Lille CHU and the pass. Its location is highly strategic in order to offer a showcase of research in oncology in Lille and Hauts de France, at the entrance to the university hospital campus, open to the public, and to bring together fundamentalist researchers and clinicians in order to promote the transfer of research to the clinic and the patient. Indeed, … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 4 | 36 |
 | EMA Pharmaceuticals Leading sealing solutions for pharma- and diagnostic applications - Made in France. EMA Pharmaceuticals is a global actor in the development, manufacturing and marketing of sealing solutions for pharmaceutical containers. Specifically focused on closures for parenteral drug applications, EMA Pharmaceuticals currently serve more than 170 production sites of injectable medicine across the 5 continents. Our ambition is to enhance patients’ safety by providing Pharmaceutical Industry worldwide with clean-certified closure systems, manufactured according highest industry standards, ensuring optimal product integrity, drug recognition and ease of use by healthcare workers. Closure Systems for Pharmaceutical Containers, Primary Packaging Materials for Parenteral Drugs, and … Type: SMB Activities: deeptech manufacturing biotech Technologies: Synthetic Biology | 1 | 43 |
 | NAOS (Bioderma - Institut Esthederm - Etat Pur) Pioneer of Ecobiology. The company behind BIODERMA, Institut Esthederm and Etat Pur. Made in France products. When he created the first BIODERMA and Institut Esthederm products in 1977, Jean-Noël Thorel, a pharmacist-biologist, paved the way for active cosmetics by integrating biology into cosmetics, with the aim of changing the paradigm. Present today in more than 100 countries, NAOS has chosen a single design and manufacturing site, NAOS Les Laboratoires, in Aix-en-Provence (France), in order to control the quality and unique design of its products. NAOS brands - BIODERMA, Institut Esthederm and Etat Pur - claim a unique approach: ecobiology. A … Type: Large company Activities: biotech cosmetics | 15 | 3,506 |
 | Andaman7 Next generation ePRO, RWE, virtual clinical trials, siteless trials... all that with a connected PHR for patients! Andaman7 is a patient driven mobile Personal Health Record and an intermediation platform to securely exchange health information with caregivers and researchers. We offer next generation trial recruiting and ePRO services to collect data remotely for life science companies, pharmaceutical companies and medical device manufacturers that need more and better patient outcomes and real world data for trials, market access and disease management. With our unique platform, you can achieve 3 goals at once: • Empowering patients • Managing diseases • Measuring outcomes … Type: Startup Activities: biotech deeptech healthtech it services Technologies: SaaS | 12 | 24 |
 | Gesynta Pharma AB Gesynta Pharma's drug candidate vipoglanstat (GS-248) is in clinical phase II development for the treatment of endometriosis – a painful, chronic inflammatory disease that affects about 10 percent of women of reproductive age. Endometriosis often leads to severely reduced quality of life, and current drug treatments are inadequate for many patients. Gesynta Pharma aims to exploit the full potential of microsomal prostaglandin E synthase-1 (mPGES-1) as a pharmacological target by developing products in areas of unmet medical need where mPGES-1 inhibition provides clear benefits compared to current therapy. Gesynta Pharma’s second drug candidate to reach clinical development, GS-073, has the … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 17 |
 | Atelerix Ltd. Gone are the days of frozen logistics; welcome to the new era of shelf-stable science with Atelerix. Crafting shelf-stable science inspired by hedgehogs, Atelerix is the answer to the cryopreservation headache. With a gel that's not just cool but doesn't need to be cold, they're setting cells, tissues, and viruses free from the icy grip of traditional storage and shipping methods. Welcome to the future of bioscience, where the storage is easy, and the cells are always fresh. Cell Storage, Cell Transport, Biomaterials, and Cellular Therapy Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 11 |